Evaluation of Effectiveness and Safety of Everolimus Eluting Stent System (XIENCE V) in the Treatment of Coronary Artery Lesions

被引:0
|
作者
Karakulak, U. N. [1 ]
Yorgun, H. [1 ]
Sahiner, L. [1 ]
Kaya, B. [1 ]
Kabakci, G. [1 ]
Aytemir, K. [1 ]
Oto, A. [1 ]
机构
[1] Hacettepe Univ, Dept Cardiol, Fac Med, Ankara, Turkey
来源
AMERICAN JOURNAL OF CARDIOLOGY | 2014年 / 113卷 / 07期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OP-069
引用
收藏
页码:S20 / S21
页数:2
相关论文
共 50 条
  • [31] Stent Thrombosis and Dual Antiplatelet Interruption: Insights from the XIENCE V Everolimus-Eluting Coronary Stent System Trials
    Stone, Gregg W.
    Rutledge, David R.
    Sudhir, Krishnankutty
    Hermiller, James B.
    Serruys, Patrick W.
    Mao, Vivian W.
    Zhao, Weiying
    Yaqub, Manejeh
    Sood, Poornima
    Wang, Jin
    Cao, Sherry
    Zheng, Qing
    Jonnavithula, Lalitha K.
    Simonton, Charles A.
    Krucoff, Mitchell W.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (20) : B23 - B24
  • [32] SAFETY AND EFFICACY OF THE XIENCE V EVEROLIMUS-ELUTING STENT COMPARED TO THE RESOLUTE ZOTAROLIMUS-ELUTING STENT IN SMALL VESSELS
    Yang Shiwei
    Liu Yuyang
    Jia Dean
    Fang Zhe
    Han Hongya
    Liu Xiaoli
    HEART, 2011, 97 : A165 - A165
  • [33] A randomized multicenter trial comparing the XIENCE everolimus eluting stent with the CYPHER sirolimus eluting stent in the treatment of female patients with de novo coronary artery lesions: The SPIRIT WOMEN study
    Franzone, Anna
    Zaugg, Serge
    Piccolo, Raffaele
    Modena, Maria Grazia
    Mikhail, Ghada W.
    Mauri Ferre, Josepa
    Strasser, Ruth
    Grinfeld, Liliana
    Heg, Dik
    Juni, Peter
    Windecker, Stephan
    Morice, Marie-Claude
    PLOS ONE, 2017, 12 (08):
  • [34] The XIENCE nano™ everolimus eluting coronary stent system for the treatment of small coronary arteries: The SPIRIT small vessel trial
    Cannon, Louis A.
    Simon, Daniel I.
    Kereiakes, Dean
    Jones, Jennifer
    Mehran, Roxana
    Kusano, Hajime
    Zhang, Zhen
    Lombardi, William
    Fleischhauer, F. James
    Costa, Marco A.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2012, 80 (04) : 546 - 553
  • [35] Randomized Comparison of Everolimus-Eluting and Paclitaxel-Eluting Stents Two-Year Clinical Follow-Up From the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SPIRIT) III Trial
    Stone, Gregg W.
    Midei, Mark
    Newman, William
    Sanz, Mark
    Hermiller, James B.
    Williams, Jerome
    Farhat, Naim
    Caputo, Ronald
    Xenopoulos, Nicholas
    Applegate, Robert
    Gordon, Paul
    White, Roseann M.
    Sudhir, Krishnankutty
    Cutlip, Donald E.
    Petersen, John L.
    CIRCULATION, 2009, 119 (05) : 680 - 686
  • [36] Clinical Outcomes in the Percutaneous Coronary Intervention of In-Stent Restenosis with the XIENCE V Everolimus-Eluting Stent
    Lee, Michael
    Yang, Tae
    Mahmud, Ehtisham
    Park, Kyung Woo
    Kim, Hyo-Soo
    Kim, Moo Hyun
    Dangas, George
    Hermiller, James, Jr.
    Krucoff, Mitchell
    Rutledge, David
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (18) : B140 - B140
  • [37] Comparison of the NOBORI Biolimus-Eluting Stent and the XIENCE/PROMUS Cobalt Chronium Everolimus-Eluting Stent in Patients With De novo Long Coronary Artery Lesions
    Hiromasa, Takashi
    Kuramitsu, Shoichi
    Jinnouchi, Hiroyuki
    Morinaga, Takashi
    Kobayashi, Yohei
    Domei, Takenori
    Soga, Yoshimitsu
    Shirai, Shinichi
    Ando, Kenji
    Nobuyoshi, Masakiyo
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (15) : B237 - B237
  • [38] A New Era of Prospective Real-World Safety Evaluation: Primary Report of XIENCE V USA (XIENCE V Everolimus Eluting Coronary Stent System Condition-of-Approval Post-Market Study)
    Krucoff, Mitchell W.
    Rutledge, David R.
    Gmberg, Luis
    Jonnavithula, Lalitha
    Katopodis, John N.
    Lombardi, William
    Mao, Vivian W.
    Sharma, Samin K.
    Simonton, Charles A.
    Tamboli, Hoshedar P.
    Wang, Jin
    Wilburn, Olivia
    Zhao, Weiying
    Sudhir, Krishnankutty
    Hermiller, James B.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2011, 4 (12) : 1298 - 1309
  • [39] A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease. Study design and rationale of the EXECUTIVE trial
    Ribichini, Flavio
    Ansalone, Gerardo
    Bartorelli, Antonio
    Beqaraj, Federico
    Berni, Andrea
    Colangelo, Salvatore
    D'Amico, Maurizio
    Della Rovere, Francesco
    Fiscella, Antonio
    Gabrielli, Gabriele
    Indolfi, Ciro
    La Vecchia, Luigi
    Loschiavo, Paolo
    Marinoni, Giampietro
    Marzocchi, Antonio
    Milazzo, Diego
    Romano, Michele
    Sangiorgio, Pietro
    Sheiban, Imad
    Tamburino, Corrado
    Tuccillo, Bernardino
    Villani, Rosvaldo
    Cappi, Barbara
    Quijada, Maria Jose Lopera
    Vassanelli, Corrado
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2010, 11 (04) : 299 - 309
  • [40] Five-Year Long-Term Clinical Follow-Up of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Patients With de novo Coronary Artery Lesions: The SPIRIT FIRST Trial
    Wiemer, Marcus
    Serruys, Patrick W.
    Miquel-Hebert, Karine
    Neumann, Franz-Josef
    Piek, Jan J.
    Grube, Eberhard
    Haase, Juergen
    Thuesen, Leif
    Hamm, Christian
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2010, 75 (07) : 997 - 1003